Report for Williams-Herman D

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1 - Migoya_2010_Clin.Pharmacol.Ther_88_801
Author(s) : Migoya EM , Bergeron R , Miller JL , Snyder RN , Tanen M , Hilliard D , Weiss B , Larson P , Gutierrez M , Jiang G , Liu F , Pryor KA , Yao J , Zhu L , Holst JJ , Deacon C , Herman G , Thornberry N , Amatruda J , Williams-Herman D , Wagner JA , SinhaRoy R
Ref : Clinical Pharmacology & Therapeutics , 88 :801 , 2010
Abstract : Migoya_2010_Clin.Pharmacol.Ther_88_801
ESTHER : Migoya_2010_Clin.Pharmacol.Ther_88_801
PubMedSearch : Migoya_2010_Clin.Pharmacol.Ther_88_801
PubMedID: 21048706

Title : Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes - Williams-Herman_2010_BMC.Endocr.Disord_10_7
Author(s) : Williams-Herman D , Engel SS , Round E , Johnson J , Golm GT , Guo H , Musser BJ , Davies MJ , Kaufman KD , Goldstein BJ
Ref : BMC Endocr Disord , 10 :7 , 2010
Abstract : Williams-Herman_2010_BMC.Endocr.Disord_10_7
ESTHER : Williams-Herman_2010_BMC.Endocr.Disord_10_7
PubMedSearch : Williams-Herman_2010_BMC.Endocr.Disord_10_7
PubMedID: 20412573

Title : Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement - Alba_2009_Curr.Med.Res.Opin_25_2507
Author(s) : Alba M , Sheng D , Guan Y , Williams-Herman D , Larson P , Sachs JR , Thornberry N , Herman G , Kaufman KD , Goldstein BJ
Ref : Curr Med Res Opin , 25 :2507 , 2009
Abstract : Alba_2009_Curr.Med.Res.Opin_25_2507
ESTHER : Alba_2009_Curr.Med.Res.Opin_25_2507
PubMedSearch : Alba_2009_Curr.Med.Res.Opin_25_2507
PubMedID: 19691426

Title : Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis - Williams-Herman_2008_BMC.Endocr.Disord_8_14
Author(s) : Williams-Herman D , Round E , Swern AS , Musser B , Davies MJ , Stein PP , Kaufman KD , Amatruda JM
Ref : BMC Endocr Disord , 8 :14 , 2008
Abstract : Williams-Herman_2008_BMC.Endocr.Disord_8_14
ESTHER : Williams-Herman_2008_BMC.Endocr.Disord_8_14
PubMedSearch : Williams-Herman_2008_BMC.Endocr.Disord_8_14
PubMedID: 18954434

Title : Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach - Xu_2008_Diabetes.Obes.Metab_10_1212
Author(s) : Xu L , Man CD , Charbonnel B , Meninger G , Davies MJ , Williams-Herman D , Cobelli C , Stein PP
Ref : Diabetes Obes Metab , 10 :1212 , 2008
Abstract : Xu_2008_Diabetes.Obes.Metab_10_1212
ESTHER : Xu_2008_Diabetes.Obes.Metab_10_1212
PubMedSearch : Xu_2008_Diabetes.Obes.Metab_10_1212
PubMedID: 18476982

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus - Raz_2006_Diabetologia_49_2564
Author(s) : Raz I , Hanefeld M , Xu L , Caria C , Williams-Herman D , Khatami H
Ref : Diabetologia , 49 :2564 , 2006
Abstract : Raz_2006_Diabetologia_49_2564
ESTHER : Raz_2006_Diabetologia_49_2564
PubMedSearch : Raz_2006_Diabetologia_49_2564
PubMedID: 17001471